Gat-Yablonski Galia, Shalitin Shlomit, Phillip Moshe
Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva.
Pediatr Endocrinol Rev. 2006 Aug;3 Suppl 3:514-20.
Maturity onset diabetes of the young (MODY) is characterized by a primary defect in insulin secretion and hyperglycemia, nonketotic disease, monogenic autosomal dominant mode of inheritance, age at onset less than 25 years, and lack of auto-antibodies. It accounts for 2-5% of all cases of non-type 1 diabetes. The diagnosis may be made by careful clinical evaluation, but exact subtyping is possible only by genetic analysis. Several genetic factors have been identified as causative agents in MODY, each leading to a different type of the disease. These include the enzyme glucokinase, which causes MODY2, and the transcription factors HNF- 4 alpha, TCF1, I PF-1, TCF2, and NeuroD1, which cause MODY1, 3, 4, 5, and 6, respectively. The genetic findings have important clinical implications, allowing for proper genetic counseling, early diagnosis, and better care of patients.
青年发病的成年型糖尿病(MODY)的特征是胰岛素分泌存在原发性缺陷和高血糖、非酮症性疾病、单基因常染色体显性遗传模式、发病年龄小于25岁以及缺乏自身抗体。它占所有非1型糖尿病病例的2%至5%。诊断可通过仔细的临床评估做出,但只有通过基因分析才能进行确切的亚型分类。已确定几种遗传因素是MODY的致病因素,每种因素导致不同类型的疾病。这些因素包括导致MODY2的葡萄糖激酶,以及分别导致MODY1、3、4、5和6的转录因子HNF-4α、TCF1、IPF-1、TCF2和NeuroD1。这些基因研究结果具有重要的临床意义,有助于进行适当的遗传咨询、早期诊断和更好地照顾患者。